Thank you for visiting Clarivate at World Drug Safety Congress 2025
Please click on the covers to download assets

Informed Risk Assessment
One of the biggest challenges the pharma industry continues to face today is the failure of drug candidates due to unexpected adverse reactions. Late-stage clinical attrition for safety reasons represents a high risk in terms of patient safety and cost. Early anticipation of safety issues enables informed decisions. In this session we will present how...